Tag: car_t_cell_therapy
-
Groundbreaking CAR T Cell Therapy Offers Potential Cures for B-Cell Lymphoma
New long-term data from Penn Medicine shows CAR T cell therapy leads to 10-year remissions and potential cures for over one-third of B-cell lymphoma patients, marking a significant advance in cancer treatment.
HealthMediaWorldSocial IssuesMedical ScienceEducationDigital and Print PublishingEnvironmentMiddle East CAR T cell therapyB-cell lymphomaCancer TreatmentRemissionPenn MedicineStephen J. SchusterFDA
-
Pioneering CAR T Cell Therapy Opens Doors for Kidney Transplant Patients
Penn Medicine's clinical trial uses CAR T cell therapy to enable kidney transplants for two end-stage patients, offering transformative hope for those on waiting lists.
HealthBusinessScience & TechnologyWeatherMedical ScienceArtificial IntelligenceEconomyReal EstateClimate ChangeEducation Penn MedicineCAR T cell therapyKidney transplantClinical trialAli NajiEnd-stage kidney diseaseMedical breakthrough